“Put simply, this is a fascinating and highly readable book that covers a vast tract of the genetics and genomics field. There is a superb mix of science and clinical angles, offering vast amounts of highly relevant reading as well as being an excellent reference source. The logical layout and clear
writing style make it easy to understand and this book deserves to reach a wide audience.” — Dr Harry Brown, Glycosmedia

–This text refers to the pocket_book edition.

Helen V. Firth, Consultant in Clinical Genetics, Cambridge University Hospitals, Cambridge, UK and Hon Faculty Member, Wellcome Trust Sanger Institute, Hinxton, UK ,Jane A. Hurst, Consultant in Clinical Genetics, Great Ormond Street Hospital, London, UK

Dr Helen Firth, DM FRCP DCH is a Consultant Clinical Geneticist at Cambridge University Hospitals, an Honorary Faculty Member of the Wellcome Trust Sanger Institute, and a Bye-Fellow of Newnham College, Cambridge. Her main research interests are in mapping the clinical genome and the matching of
rare genomic variants to empower discovery and diagnosis in rare disease.

In 2004, she initiated the DECIPHER project (http://decipher.sanger.ac.uk) that enables clinicians and scientists around the world to share information about rare genomic variants to facilitate diagnosis and help to elucidate the role of genes whose function is not yet known. In 2010 Dr Firth became
Clinical Lead for the Deciphering Developmental Disorders study (DDD study) (http://www.ddduk.org), one of the world’s largest nationwide, genome-wide sequencing projects in rare disease. The study aims to improve diagnosis and further understanding of the genomic architecture of severe
developmental disorders.

Dr Jane Hurst is a clinician working full time as a clinical geneticist in the one of the leading children’s hospitals in the world; a centre of excellence for the diagnosis and treatment of rare diseases. She moved to her current post in 2010 to lead the dysmorphology service after 18 years working
in Oxford, UK.

Although primarily a patient-focussed clinician, she has always worked closely with scientific colleagues by identifying families that give important clues to the genetic aetiology. Thus early in her career she identified the first family shown to have leptin deficiency and the two families that led
to the cloning of the FOXP2 gene.
–This text refers to the pocket_book edition.